Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapid methods for bioavailability determination utilizing urinary excretion data.

P J Niebergall, E T Sugita, R L Schnaare

    Journal of Pharmaceutical Sciences
    |October 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of formulation composition and dissolution parameters on the gel strength of controlled release hydrogel tablets.

    Pharmaceutical development and technology·2002
    Same author

    Antimicrobial and diffusional correlation of N-alkyl betaines and N-alkyl-N,N-dimethylamine oxides from semisolids.

    Journal of pharmaceutical sciences·2001
    Same author

    Cross-linked hemoglobin as a potential membrane for an artificial red blood cell.

    Artificial cells, blood substitutes, and immobilization biotechnology·2001
    Same author

    A novel method for measuring gel strength of controlled release hydrogel tablets using a cone/plate rheometer.

    Pharmaceutical development and technology·2001
    Same author

    The antioxidant system beta-D(+) glucose-glucose oxidase-catalase: tests for pyrogenicity and antigenicity.

    Pharmaceutical development and technology·2001
    Same author

    Antimicrobial evaluation of N-alkyl betaines and N-alkyl-N, N-dimethylamine oxides with variations in chain length.

    Antimicrobial agents and chemotherapy·2000
    Same journal

    Immune tolerance platforms to mitigate unwanted immune responses.

    Journal of pharmaceutical sciences·2026
    Same journal

    Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

    Journal of pharmaceutical sciences·2026
    Same journal

    Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

    Journal of pharmaceutical sciences·2026
    Same journal

    Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

    Journal of pharmaceutical sciences·2026
    Same journal

    Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

    Journal of pharmaceutical sciences·2026
    Same journal

    A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

    Journal of pharmaceutical sciences·2026
    See all related articles

    New equations estimate drug bioavailability using urinary excretion data within 12 hours. This method aids in understanding drug absorption, distribution, and elimination kinetics for improved pharmaceutical development.

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism and Elimination

    Background:

    • Accurate estimation of drug bioavailability is crucial for therapeutic efficacy and safety.
    • Traditional methods may require extensive sampling or complex modeling.

    Purpose of the Study:

    • To develop and validate novel equations for estimating drug bioavailability.
    • To utilize readily available urinary excretion data for bioavailability assessment.

    Main Methods:

    • Development of two distinct mathematical equations.
    • Testing equations with simulated data from one- and two-compartment pharmacokinetic models.
    • Validation of one equation using existing literature data.

    Main Results:

    • The developed equations enable bioavailability estimation from urinary data within a 12-hour window.

    Related Experiment Videos

  • Simulated data supported the applicability of the equations across different pharmacokinetic models.
  • Excellent agreement was observed when testing one equation with literature data.

    • Conclusions:

    • Urinary excretion data can be effectively leveraged to determine drug bioavailability.
    • The developed equations offer a practical and efficient approach for pharmacokinetic analysis.
    • These methods can potentially streamline drug development and clinical monitoring.